Explain this page
Arphra AIPlain-English read on Zoetis Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$296.83
+261.11% vs spot
Recommendation
Strong Buy
17 of 19 methods
Method spread
11bull6bear
±5% threshold
Analyst PT consensus: $143.00 (+73.97%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.29% | +3.34% | -0.76% | -31.78% | -30.38% | -34.67% | -50.81% | -50.35% | -54.86% | +73.45% | +165.08% |
Insider · 30d
History →Bought
$886.37K
3 txns
Sold
$3.02M
7 txns
Net flow
−$2.14M
Aftermarket
LiveLast trade
$81.85
1 sh
Bid
$81.85
100 sh
Ask
$82.48
100 sh
Spread
$0.630
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $2.39B | $603M | $1.37 |
| Q3 Sep 2025 | $2.4B | $721M | $1.63 |
| Q2 Jun 2025 | $2.46B | $718M | $1.61 |
| Q1 Mar 2025 | $2.22B | $631M | $1.41 |
| Q4 Dec 2024 | $2.32B | $581M | $1.29 |
| Q3 Sep 2024 | $2.39B | $682M | $1.50 |
Sector & industry today
LiveSectors
- Real Estate+1.94%
- Consumer Cyclical+1.72%
- Consumer Defensive+1.71%
- Communication Services+0.33%
- Financial Services+0.21%
- Industrials+0.19%
- Basic Materials+0.08%
- Healthcare-0.22%
- Utilities-0.29%
- Energy-1.13%
- Technology-1.58%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-1.14%
- Solar-7.33%
- Furnishings, Fixtures & Appliances+5.13%
- Investment - Banking & Investment Services-4.94%
- Computer Hardware-4.91%
- Medical - Equipment & Services+3.95%
- Silver-3.66%
- Financial - Mortgages+3.52%
- Hardware, Equipment & Parts-3.36%
- Home Improvement+3.35%
- Software - Infrastructure-3.30%
- Apparel - Manufacturers+3.21%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$143.00
+73.97% upside
Low
$130.00
Median
$140.00
High
$160.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZTSnewsfilecorp.com·Jun 09, 2026
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZTSnewsfilecorp.com·Jun 09, 2026
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTSglobenewswire.com·Jun 09, 2026
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTSglobenewswire.com·Jun 09, 2026
- Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuitprnewswire.com·Jun 09, 2026
- Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuitprnewswire.com·Jun 09, 2026
- ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firmglobenewswire.com·Jun 09, 2026
- ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firmglobenewswire.com·Jun 09, 2026
Peers
- ELVElevance Health Inc.$372.68$80.93B
- CICigna Corporation$282.90$74.59B
- REGNRegeneron Pharmaceuticals, Inc.$701.42$72.26B
- CORCencora, Inc.$304.00$59.14B
- BDXBecton, Dickinson and Company$149.31$54.09B
- TAKTakeda Pharmaceutical Company Limited$16.62$52.51B
- ARGXargenx SE$783.50$48.49B
- IDXXIDEXX Laboratories, Inc.$567.46$45.18B
Total assets
$15.47B
Total debt
$9.49B
Cash & equiv
$2.31B
Operating CF
$2.9B
Free cash flow
$2.28B
Buybacks
-$3.24B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
DAMELIO FRANK A director | Buy | 6,650 | $501.34K | May 13, 2026 |
Bisaro Paul director | Buy | 2,000 | $151.75K | May 13, 2026 |
MCCALLISTER MICHAEL B director | Buy | 3,000 | $233.27K | May 11, 2026 |
PECK KRISTIN C director, officer: Chief Executive Officer | Sell | 10,800 | $1.38M | Feb 17, 2026 |
PECK KRISTIN C director, officer: Chief Executive Officer | Sell | 9,200 | $1.16M | Feb 17, 2026 |
Lagano Roxanne officer: Executive Vice President | Sell | 652 | $110.84K | Jun 03, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $9.47B | $3.6B | $2.67B | $6.02 | +28.23% |
| FY 2024 | $9.26B | $3.39B | $2.49B | $5.47 | +26.86% |
| FY 2023 | $8.54B | $3.07B | $2.34B | $5.07 | +27.43% |
| FY 2022 | $8.08B | $2.93B | $2.11B | $4.49 | +26.16% |
| FY 2021 | $7.78B | $2.8B | $2.04B | $4.27 | +26.20% |